Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a).

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Kidney International

• Publication date

  1998-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1523-1755.1998.00086.XPMID 9767560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specimen collection and preservation

  1999cited by this paper
• Atherosclerosis and arteriosclerosis in chronic renal failure.

  1997cited by this paper
• Lipoprotein(a) in renal disease.

  1996cited by this paper
• Lipoprotein(a) in health and disease.

  1996cited by this paper
• Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.

  1995cited by this paper
• Lipoprotein(a) levels in hemodialysis patients: relation to glucose intolerance and hemodialysis duration.

  1995cited by this paper
• Prediction of reduction in predialysis concentrations due to interdialysis weight gain.

  1995cited by this paper
• Effects of erythropoietin therapy on the lipid profile in end-stage renal failure.

  1994cited by this paper
• Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides.

  1994cited by this paper
• Quantitation of Plasma Apolipoproteins in the Primary and Secondary Prevention of Coronary Artery Disease

  1994cited by this paper
• Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism.

  1993cited by this paper
• Lipoprotein (a) levels in end-stage renal failure and renal transplantation.

  1993cited by this paper
• Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus.

  1993cited by this paper
• Lipoprotein (a) in patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis.

  1993cited by this paper
• Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).

  1993cited by this paper
• Lipid abnormalities in renal disease.

  1991cited by this paper
• Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis.

  1987cited by this paper
• Precautionary measures for collecting blood destined for lipoprotein isolation.

  1986cited by this paper
• Effect of posture on serum lipids.

  1973cited by this paper
• [The effect of deproteinization on the results of serum and plasma analyses].

  1967cited by this paper
• CHOLESTEROL MEASUREMENT IN SERUM AND IN PLASMA.

  1964cited by this paper
• A study of the estimation of sodium in blood serum.

  1936cited by this paper

• Repeated measurement of lipoprotein(a): technical versus biological variability.

  2025cites this paper
• Towards the clinical use of peripheral bile acids: Recommendations to limit their preanalytical and analytical sources of variability

  2025cites this paper
• Sample Preparation for Metabolomic Analysis in Exercise Physiology

  2024cites this paper
• Prolonged release from lipid nanoemulsions by modification of drug lipophilicity.

  2024cites this paper
• Dried blood spot-based free sterol signatures in sitosterolemia diagnostics.

  2024cites this paper
• Serum afamin and its implications in adult growth hormone deficiency: a prospective GH-withdrawal study

  2024cites this paper
• Plasma and serum metabolic analysis of healthy adults shows characteristic profiles by subjects’ sex and age

  2024cites this paper
• Serum and plasma as a good candidates of body fluids for detection lung cancer by FTIR liquid biopsy

  2024cites this paper
• Controlling pre-analytical process in human serum/plasma metabolomics

  2023cites this paper
• Stability Studies of Kynurenine Pathway Metabolites in Blood Components Define Optimal Blood Processing Conditions

  2023cites this paper
• Pre-analytical variables influence zinc measurement in blood samples

  2023cites this paper
• Plasma versus Serum Analysis by FTIR Spectroscopy to Capture the Human Physiological State

  2022cites this paper
• Genetic correlates of vitamin D-binding protein and 25-hydroxyvitamin D in neonatal dried blood spots

  2022cites this paper
• Endocannabinoids as potential biomarkers: It's all about pre-analytics.

  2021cites this paper
• Recommendations and Best Practices for Standardizing the Pre-Analytical Processing of Blood and Urine Samples in Metabolomics

  2020cites this paper
• Fast LC-ESI-MS/MS analysis and influence of sampling conditions for gut metabolites in plasma and serum

  2019cites this paper
• Subclinical atherosclerosis in patients with cyanotic congenital heart disease.

  2019cites this paper
• Neonatal İshalli Buzağılarda İki Farklı Hematokrit Ölçüm Tekniğinin Karşılaştırılması

  2018cites this paper
• Sample management for clinical biochemistry assays: Are serum and plasma interchangeable specimens?

  2018cites this paper
• Systematic evaluation of serum and plasma collection on the endogenous metabolome.

  2017cites this paper
• Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington’s disease peripheral blood samples

  2016cites this paper
• Lipoprotein(a) in various conditions: to keep a sense of proportions.

  2014cites this paper
• Chronic kidney disease on hemodialysis is associated with decreased serum PCSK9 levels.

  2014cites this paper
• Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk.

  2014cites this paper
• Metabolomics analyses to better understand complex phenotypes

  2013cites this paper
• Diurnal variation of phenylalanine and tyrosine concentrations in adult patients with phenylketonuria: subcutaneous microdialysis is no adequate tool for the determination of amino acid concentrations

  2013cites this paper
• Serum Proteome Changes in Dengue Virus-Infected Patients from a Dengue-Endemic Area of India: Towards New Molecular Targets?

  2012cites this paper
• Differences between Human Plasma and Serum Metabolite Profiles

  2011cites this paper
• Exposures to multiple environmental chemicals (lead, methylmercury and polychlorinated biphenyls) among childbearing-aged women in the U.S.

  2011cites this paper
• Decrease of Lp(a) during weight reduction in obese children is modified by the apo(a) kringle-IV copy number variation

  2009cites this paper
• In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients.

  2007cites this paper
• Sclerosing Encapsulating Peritonitis : A Case Successfully Treated with Immunosuppression Sclerosing encapsulating peritonitis

  2006cites this paper
• Lipoprotein in Hemodialysis Patients as Potential Cause of Premature Atherosclerosis Delayed In Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density

  2005cites this paper
• Delayed In Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density Lipoprotein in Hemodialysis Patients as Potential Cause of Premature Atherosclerosis

  2005cites this paper
• Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation

  2003cites this paper
• Inflammatory Markers and Platelet Aggregation Tests as Predictors of Hemoglobin and Endogenous Erythropoietin Levels in Hemodialysis Patients

  2002cites this paper
• Study of hemolysis interference with a peak rate nephelometric assay of lipoprotein(a)

  2000cites this paper
• Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.

  2000cites this paper
• Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up.

  1999cites this paper
• Effect of Erythropoietin Therapy on Serum Apolipoprotein A1 Levels in Patients Undergoing Chronic Peritoneal Dialysis

  1999influential citation
• The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up.

  1999cites this paper